Related Experiment Video
Updated: Jan 26, 2026
09:49
Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
Published on: December 28, 2021
3.9K
Visceral adiposity index is useful for evaluating obesity effect on erectile dysfunction
Alp Ozgur Akdemir1, Mehmet Karabakan2, Binhan Kagan Aktas1
1Department of Urology, Ankara Numune Research and Training Hospital, Ankara, Turkey.
Andrologia
|April 3, 2019
Summary
Obesity is linked to a higher risk of erectile dysfunction (ED). The visceral adiposity index (VAI), a measure of obesity, was significantly higher in men with ED, suggesting its utility in assessing obesity
Area of Science:
- Urology
- Metabolic Syndrome
- Andrology
Background:
- Erectile dysfunction (ED) is frequently associated with obesity.
- Obesity assessment traditionally uses waist circumference (WC) and body mass index (BMI).
- Visceral adiposity index (VAI) offers a refined method for evaluating obesity and metabolic syndrome.
Purpose of the Study:
- To investigate the relationship between visceral adiposity index (VAI) and erectile dysfunction (ED).
Main Methods:
- Retrospective analysis of 176 male patients with erection complaints and 122 controls.
- Assessment of erectile function using the International Erectile Function Index-5 (IIEF-5).
- Measurement of VAI, WC, BMI, fasting blood glucose, total testosterone, triglycerides, LDL, and HDL cholesterol.
Main Results:
- The mean VAI was significantly higher in the ED group (5.32 ± 2.77) compared to the control group (4.11 ± 1.93).
- VAI integrates physical and metabolic parameters, potentially clarifying the impact of WC, BMI, HDL, and TG on ED.
- A statistically significant difference in VAI was observed between groups (p < 0.001).
Conclusions:
- Visceral adiposity index (VAI) is a valuable tool for assessing the influence of obesity on erectile dysfunction.
- Elevated VAI may serve as an indicator for obesity-related sexual dysfunction in men.
Related Concept Videos
01:24Obesity
1.2K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.2K
01:21Drug Dosing: Obese Patients
238
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
238
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
266
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
266
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
175
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
175
03:00Self-Evaluation: Self-Enhancement and Self-Verification
5.8K
Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
5.8K
01:15Nursing Evaluation
4.2K
The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
4.2K